Abstract
Due to the combination of effective cervical screening and prophylactic vaccination by the HPV (human papillomavirus) vaccines, cervical cancer has become a preventable cancer. In May 2018, the WHO announced a global call for action to eliminate cervical cancer. The evolution and implementation of cervical cancer screening and HPV vaccines and the global strategy instigated by the WHO are moving humankind toward the elimination of cervical cancer, although there are still many challenges to overcome. This chapter summarizes the status of HPV vaccination in the world, including the effectiveness and safety of HPV vaccines available at present. Real-world data from three countries with successful national HPV vaccine programs show that elimination of cervical cancer is no longer impossible through regional efforts and international cooperation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arbyn M, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5:CD009069.
Bruni L, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Prev Med. 2021;144:106399.
Departmental News. WHO updates recommendations on HPV vaccination schedule. 2022; https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule. Accessed 21 Feb 2023.
WHO Human Papillomavirus (HPV) vaccination coverage. https://immunizationdata.who.int/pages/coverage/hpv.html?GROUP=WHO_REGIONS&ANTIGEN=15HPV1_F&YEAR=&CODE=. Accessed 10 Mar 2023.
Joura EA, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372:711–23.
Huh WK, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet. 2017;390:2143–59.
Garland SM, et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63:519.
Tabrizi SN, et al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect Dis. 2014;14:958.
Palmer T, et al. Prevalence of cervical disease at age 20 after immunization with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study. BMJ. 2019;365:1161.
Lei J, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383:1340.
Falcaro M, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021;398:2084.
Kjaer SK, et al. Real-world effectiveness of human papillomavirus vaccination against cervical cancer. J Natl Cancer Inst. 2021;113:1329.
Phillips A, et al. Safety of human papillomavirus vaccines: an updated review. Drug Saf. 2018;41:329.
Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization 2020. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Accessed 21 Feb 2023.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Miyagi, E. (2024). Evidence and Implementation of HPV Vaccination. In: Aoki, D. (eds) Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer. Comprehensive Gynecology and Obstetrics. Springer, Singapore. https://doi.org/10.1007/978-981-99-9396-3_5
Download citation
DOI: https://doi.org/10.1007/978-981-99-9396-3_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-9395-6
Online ISBN: 978-981-99-9396-3
eBook Packages: MedicineMedicine (R0)